169 related articles for article (PubMed ID: 32927736)
81. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
Wang J; Xiao SH; Manley JL
Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066
[TBL] [Abstract][Full Text] [Related]
82. Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35. Implications for Alzheimer's disease.
Hernández F; Pérez M; Lucas JJ; Mata AM; Bhat R; Avila J
J Biol Chem; 2004 Jan; 279(5):3801-6. PubMed ID: 14602710
[TBL] [Abstract][Full Text] [Related]
83. Endogenous Jmjd6 gene product is expressed at the cell surface and regulates phagocytosis in immature monocyte-like activated THP-1 cells.
Zakharova L; Dadsetan S; Fomina AF
J Cell Physiol; 2009 Oct; 221(1):84-91. PubMed ID: 19492415
[TBL] [Abstract][Full Text] [Related]
84. A functional interaction between the carboxy-terminal domain of RNA polymerase II and pre-mRNA splicing.
Du L; Warren SL
J Cell Biol; 1997 Jan; 136(1):5-18. PubMed ID: 9008699
[TBL] [Abstract][Full Text] [Related]
85. Evolution and conservation of JmjC domain proteins in the green lineage.
Huang Y; Chen D; Liu C; Shen W; Ruan Y
Mol Genet Genomics; 2016 Feb; 291(1):33-49. PubMed ID: 26152513
[TBL] [Abstract][Full Text] [Related]
86. SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs.
Sureau A; Gattoni R; Dooghe Y; Stévenin J; Soret J
EMBO J; 2001 Apr; 20(7):1785-96. PubMed ID: 11285241
[TBL] [Abstract][Full Text] [Related]
87. PSKH1, a novel splice factor compartment-associated serine kinase.
Brede G; Solheim J; Prydz H
Nucleic Acids Res; 2002 Dec; 30(23):5301-9. PubMed ID: 12466556
[TBL] [Abstract][Full Text] [Related]
88. SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing.
Zahler AM; Damgaard CK; Kjems J; Caputi M
J Biol Chem; 2004 Mar; 279(11):10077-84. PubMed ID: 14703516
[TBL] [Abstract][Full Text] [Related]
89. Phosphorylation regulates in vivo interaction and molecular targeting of serine/arginine-rich pre-mRNA splicing factors.
Yeakley JM; Tronchère H; Olesen J; Dyck JA; Wang HY; Fu XD
J Cell Biol; 1999 May; 145(3):447-55. PubMed ID: 10225947
[TBL] [Abstract][Full Text] [Related]
90. Design and synthesis of N-(1-(6-(substituted phenyl)-pyridazin-3-yl)-piperidine-3-yl)-amine derivatives as JMJD6 inhibitors.
Qian Y; Ao M; Li B; Kuang Z; Wang X; Cao Y; Li J; Qiu Y; Guo K; Fang M; Wu Z
Bioorg Chem; 2022 Dec; 129():106119. PubMed ID: 36116323
[TBL] [Abstract][Full Text] [Related]
91. Osteopontin-c isoform levels are associated with SR and hnRNP differential expression in ovarian cancer cell lines.
Marques DS; Grativol J; Alves da Silva Peres R; da Rocha Matos A; Gimba ERP
Tumour Biol; 2017 Sep; 39(9):1010428317725442. PubMed ID: 28936921
[TBL] [Abstract][Full Text] [Related]
92. Interactions of Arabidopsis RS domain containing cyclophilins with SR proteins and U1 and U11 small nuclear ribonucleoprotein-specific proteins suggest their involvement in pre-mRNA Splicing.
Lorkovic ZJ; Lopato S; Pexa M; Lehner R; Barta A
J Biol Chem; 2004 Aug; 279(32):33890-8. PubMed ID: 15166240
[TBL] [Abstract][Full Text] [Related]
93. Cold-dependent alternative splicing of a Jumonji C domain-containing gene MtJMJC5 in Medicago truncatula.
Shen Y; Wu X; Liu D; Song S; Liu D; Wang H
Biochem Biophys Res Commun; 2016 May; 474(2):271-276. PubMed ID: 27086112
[TBL] [Abstract][Full Text] [Related]
94. Crystal Structure of the 2-Oxoglutarate- and Fe(II)-Dependent Lysyl Hydroxylase JMJD6.
Mantri M; Krojer T; Bagg EA; Webby CA; Butler DS; Kochan G; Kavanagh KL; Oppermann U; McDonough MA; Schofield CJ
J Mol Biol; 2010 May; ():. PubMed ID: 20685276
[TBL] [Abstract][Full Text] [Related]
95. JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer.
Cioni B; Ratti S; Piva A; Tripodi I; Milani M; Menichetti F; Langella T; Botti L; De Cecco L; Chiodoni C; Lecis D; Colombo MP
Mol Cancer Res; 2023 Jun; 21(6):614-627. PubMed ID: 36867680
[TBL] [Abstract][Full Text] [Related]
96. The 2-oxoglutarate-dependent oxygenase JMJD6 catalyses oxidation of lysine residues to give 5S-hydroxylysine residues.
Mantri M; Loik ND; Hamed RB; Claridge TD; McCullagh JS; Schofield CJ
Chembiochem; 2011 Mar; 12(4):531-4. PubMed ID: 22238144
[TBL] [Abstract][Full Text] [Related]
97. Distinct roles of hnRNPH1 low-complexity domains in splicing and transcription.
Kim GH; Kwon I
Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34873036
[TBL] [Abstract][Full Text] [Related]
98. Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer.
Zheng H; Tie Y; Fang Z; Wu X; Yi T; Huang S; Liang X; Qian Y; Wang X; Pi R; Chen S; Peng Y; Yang S; Zhao X; Wei X
Signal Transduct Target Ther; 2019; 4():24. PubMed ID: 31637004
[TBL] [Abstract][Full Text] [Related]
99. Prognostic and diagnostic significance of preoperative Jumonji domain‑containing 6 antibodies in colorectal cancer.
Yoshida K; Hiwasa T; Ito M; Ushigome M; Takizawa H; Li SY; Zhang BS; Iwadate Y; Funahashi K; Shimada H
Oncol Lett; 2023 Mar; 25(3):127. PubMed ID: 36844622
[TBL] [Abstract][Full Text] [Related]
100. Jmjd6 regulates ES cell homeostasis and enhances reprogramming efficiency.
Ji G; Xiao X; Huang M; Wu Q
Heliyon; 2022 Mar; 8(3):e09105. PubMed ID: 35846449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
